OHSU in the news

Editorial: Giving voice to choices at life's end

Albany Democrat-Herald December 06, 2018
OHSU research finds 45 percent of Oregonians who died in 2015 and 2016 had a Physician Order for Life-Sustaining Treatment, with editorial noting POLST’s increased usage.

Relapsed/refractory diffuse large B-cell lymphoma

Cure Today December 05, 2018
In continued coverage regarding longer-term study results for a form of gene transfer therapy treatment, Richard Maziarz, M.D., says: “What we see is that we're approaching a plateau, and we're definitely seeing a change in the natural history of the disease.”

CAR T-cell responses prove durable in ALL, DLBCL

MedPage Today December 01, 2018
Research led by Richard Maziarz, M.D., on the durability of gene transfer therapy treatment for patients with a form of lymphoma publishes in The New England Journal of Medicine and is presented at the American Society of Hematology annual conference.
See more stories